Lv1
98 积分 2023-11-15 加入
Isolation of Single Chain Antibodies Specific to Lysophosphatidic Acid Receptor 1 (LPA1) from a M13 Phage Display Library Using Purified LPA1 Stabilized in Nanodiscs
11天前
已完结
Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding
16天前
已完结
Restoring the potency of a neutralizing antibody via guided hypermutation with hyper-antibody editor HAE1
29天前
已完结
Restoring the potency of a neutralizing antibody via guided hypermutation with hyper-antibody editor HAE1
1个月前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
2个月前
已完结
177a: FIRST-IN-CLASS ORAL TL1A NANOBODY AND LONG-ACTING TL1A/IL-23 BISPECIFIC NANOBODY: NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE
3个月前
已关闭
Protein engineering by cell-surface display
4个月前
已完结
By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling
4个月前
已完结
Antibody Affinity and Stability Maturation by Error-Prone PCR
4个月前
已完结
Structural Considerations in Affinity Maturation of Antibody-Based Biotherapeutic Candidates
4个月前
已完结
皖公网安备34019202002308
